Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001818382-24-000210
Filing Date
2024-11-20
Accepted
2024-11-20 19:10:08
Documents
1
Group Members
BRADY W DOUGAN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A humaschedule13d_a9.htm SC 13D/A 93322
  Complete submission text file 0001818382-24-000210.txt   94784
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Subject) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91701 | Film No.: 241481734
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 35 WILSHIRE ROAD GREENWICH CT 06831
Business Address
Niklason Laura E (Filed by) CIK: 0001878075 (see all company filings)

Type: SC 13D/A